⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11113778 | 0.97 | — | — | |
| SCHEMBL355337 | 0.82 | — | — | |
| Bromide SCHEMBL15309464 | 0.80 | — | — | |
| SCHEMBL11112481 | 0.80 | — | — | |
| SCHEMBL9368368 | 0.65 | — | — | |
| SCHEMBL5074927 | 0.63 | — | — | |
| SCHEMBL8710484 | 0.62 | — | — | |
| SCHEMBL3974043 | 0.62 | — | — | |
| SCHEMBL867291 | 0.62 | — | — | |
| SCHEMBL13508674 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066570-A1 | LAMINATE DEVICE WITH METALLIC AND POLYMER LAYERS | QUANTUM MICROMATERIALS INC (US) | 2025-02-27 | — | — | US | claimed |
| US-20230357578-A1 | AIRTIGHT FILM WITH CERAMIC SEALING LAYER AND POLYMER SEALING LAYER | Quantum MicroMaterials, Inc. | 2023-11-09 | — | — | US | claimed |
| EP-1332132-B1 | ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES | UCB PHARMA SA (BE) | 2007-10-10 | — | — | EP | claimed |
| US-6780874-B2 | AUTOIMMUNE DISEASE; ANTIINFLAMMATORY AGENTS; ANTIPROLIFERATIVE AGENT | CELLTECH R & D LIMITED (GB) | 2004-08-24 | — | — | US | claimed |
| US-20030229116-A1 | ENAMINE DERIVATIVES | UCB PHARMA S.A. (BE) | 2003-12-11 | — | — | US | claimed |
| EP-1332132-A2 | ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES | Celltech R&D Limited (GB) | 2003-08-06 | — | — | EP | claimed |
| US-20020037909-A1 | Enamine derivatives | UCB PHARMA S.A. (BE) | 2002-03-28 | — | — | US | claimed |
| WO-2001079173-A2 | ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES | CELLTECH R & D LIMITED (GB) | 2001-10-25 | — | — | WO | claimed |
| US-12595234-B2 | Bioactive benzocycloheptene analogues from himachalenes and its applications | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2026-04-07 | — | — | US | disclosed |
| CN-121537347-A | 6, 7-Dihydro-cyclopenta [ b ] pyridine-5-ketone and synthetic method and application thereof | 上海毕得医药科技股份有限公司 | 2026-02-17 | — | — | CN | disclosed |
| US-20250304594-A1 | METHYL (R)-2-(FLUOROMETHYL)-5-OXO-4-PHENYL-4,5,6,7-TETRAHYDRO-1H-CYCLOPENTA[B]PYRIDINE-3-CARBOXYLATE AND METHYL (R)-2-(FLUOROMETHYL)-5-OXO-4-PHENYL-1,4,5,7-TETRAHYDROFURO[3,4-B]PYRIDINE-3-CARBOXYLATE AS Cav1,2 ACTIVATORS | NOVARTIS AG (CH) | 2025-10-02 | — | — | US | disclosed |
| US-12365690-B2 | Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[B]pyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyrodine-3-carboxylate as Cav1.2 activators | NOVARTIS AG (CH) | 2025-07-22 | — | — | US | disclosed |
| CN-115836076-B | Compounds as CAV1.2 activators | 诺华股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119859377-A | Polyacetal resin composition | 旭化成株式会社 | 2025-04-22 | — | — | CN | disclosed |
| US-5071871-A | Pharmaceutically useful benzo(β)pyranes and pyranopyridines | SANDOZ LTD. (CH) | 1991-12-10 | — | — | US | disclosed |
| EP-0299727-B1 | THERAPEUTIC AGENTS | Pfizer Limited (GB) | 1991-11-13 | — | — | EP | disclosed |
| EP-0422450-A2 | Chroman derivatives | MERCK PATENT GmbH (DE) | 1991-04-17 | — | — | EP | disclosed |
| US-4992447-A | Asthma | PFIZER INC. (US) | 1991-02-12 | — | — | US | disclosed |
| EP-0299727-A1 | Therapeutic agents | Pfizer Limited (GB) | 1989-01-18 | — | — | EP | disclosed |
| US-4334010-A | Silver halide photographic light-sensitive element | FUJI PHOTO FILM CO., LTD. (JP) | 1982-06-08 | — | — | US | disclosed |